Is there a coupon or savings card for tirzepatide?

Yes, but only for the two FDA-approved brands, sold under separate programs. Eli Lilly's Zepbound savings card can lower an eligible commercially insured patient's copay by up to 150 dollars per fill, with a 25 dollar minimum payment and an annual cap. The Mounjaro savings card works the same way for the type 2 diabetes indication. Neither is a universal coupon, and neither applies outside a pharmacy-filled, insurance-billed prescription.

Can I use GoodRx or SingleCare for tirzepatide?

A pharmacy discount card will generate a price at a participating pharmacy, but for a brand-name drug with no generic equivalent, that price is often close to or above the manufacturer's own cash-pay program, since discount cards work by negotiating off a pharmacy's list price rather than replacing it with a flat program price. It is worth comparing the discount card's quote against LillyDirect's self-pay tiers before assuming the discount card is cheaper.

Do savings cards or coupons work with compounded or research-use tirzepatide?

No. Manufacturer savings cards and pharmacy discount cards both process against a National Drug Code at a licensed pharmacy billing a specific prescription. Compounded tirzepatide is not sold under the manufacturer's NDC, and research-use material is not dispensed through a pharmacy at all, so there is no billing pathway for either program to apply to.

What if I don't have insurance and can't use a savings card?

A few routes remain. LillyDirect's self-pay program offers a flat cash price independent of insurance, patient assistance programs provide free or reduced-cost medication to qualifying uninsured patients on an income basis, and the research-compound market is a separate, uninsured-by-design lane entirely. The full route-by-route cost comparison is in how to get tirzepatide cheaper.

Does the Zepbound savings card work for a Mounjaro prescription, or the reverse?

No. Zepbound and Mounjaro are the same molecule under two brand names tied to two different FDA-approved indications, chronic weight management and type 2 diabetes respectively, and Lilly runs a separate savings card for each, matched to the prescription's specific indication and brand.

Tirzepatide Coupons and Savings Cards: What Actually Cuts the Price in 2026

Quick answer

Eli Lilly runs two separate manufacturer savings cards, one for Zepbound and one for Mounjaro, each capable of lowering an eligible commercially insured patient's copay by up to 150 dollars per fill, with a 25 dollar minimum payment per fill. ^[1]
The Zepbound card caps total savings at 1,300 dollars a year across a lifetime limit of 13 fills; the Mounjaro card caps at 1,950 dollars a year. ^[1] ^[2]
Both cards require commercial insurance that covers the specific brand and a prescription filled at a licensed pharmacy. Medicare, Medicaid, TRICARE, and other government-funded plans are excluded from either program. ^[1] ^[2]
None of these coupon mechanisms, including pharmacy discount cards like GoodRx, can apply to compounded or research-use tirzepatide, because all of them process against a National Drug Code at a pharmacy, and neither compounded nor research-use material is dispensed that way.

A tirzepatide coupon sounds like a single thing to look for, but the search actually covers at least five distinct mechanisms: two manufacturer savings cards tied to two different brands, pharmacy discount cards, income-based patient assistance programs, and the manufacturer's own direct-to-consumer cash price. Each works differently, qualifies a different person, and discounts a different starting price. None of them apply to the research-compound market, for a structural reason worth understanding before assuming a coupon will help.

How tirzepatide coupons and savings cards actually work

Tirzepatide discount mechanisms compared

Mechanism	What it discounts	Requires insurance	Applies to compounded or research-use tirzepatide
Zepbound manufacturer savings card	Copay on a pharmacy-filled Zepbound prescription, up to 150 dollars per fill	Yes, commercial insurance covering Zepbound	No
Mounjaro manufacturer savings card	Copay on a pharmacy-filled Mounjaro prescription, up to 150 dollars per fill	Yes, commercial insurance covering Mounjaro	No
Pharmacy discount card (GoodRx, SingleCare)	Negotiated cash price at a participating retail pharmacy	Prescription yes, insurance no	No
Patient assistance program	Free or reduced-cost medication for qualifying uninsured patients	Prescription yes, insurance no	No
LillyDirect self-pay	Flat monthly cash price purchased directly from the manufacturer	Prescription yes, insurance no	No
Research-compound market pricing	Per-vial price for research-use material, no pharmacy involved	No prescription, no insurance	This is the lane itself

Every row except the last one routes through a pharmacy and a National Drug Code, the identifier a pharmacy's billing system uses to match a claim to a specific manufactured product. That is the mechanical reason a coupon works at all, and it is also the reason the coupon stops working the moment the product being purchased is not the one the code points to.

I signed up for the Zepbound savings card the same week I started comparing prices, assuming it would just knock a flat amount off whatever I ended up paying, including a research-compound order I was pricing out as a backup. It took a call to the card's own support line to learn that the card only activates at the pharmacy counter, against a claim my insurance had already approved.

Once I understood that, I went back to basics: what does my plan actually cover, and what does the card save on top of that specific coverage. The card ended up saving me a meaningful amount on my actual Zepbound copay, close to the advertised maximum, but it never touched the separate cost comparison I was running against the research market.

The mistake cost me a week of assuming a discount existed where it did not. Once the two tracks were separated, comparing them honestly took about twenty minutes.

— Trevor Lindqvist, Salt Lake City, UT

The Zepbound savings card: what it actually pays for

The Zepbound card is built for one specific gap: a patient whose commercial plan covers the drug but still leaves a copay that is expensive on its own. Eligibility requires commercial insurance that covers Zepbound for the FDA-approved chronic weight management indication, a valid prescription, and enrollment through Lilly's own program terms, which the manufacturer can revise or end at any time. ^[1] ^[3] The card is not available to anyone enrolled in Medicare, Medicaid, TRICARE, or another government-funded health program, regardless of how the prescription is written. ^[1]

At current published terms, the card can knock up to 150 dollars off a single fill, with a required minimum payment of 25 dollars, and a total annual ceiling of 1,300 dollars spread across as many as 13 fills. ^[1] Those specific dollar figures are the kind of detail a manufacturer program changes on its own schedule, so the number worth confirming before relying on the card is not the one printed in an old blog post, it is the one on Lilly's own savings page at the moment of use. For anyone weighing the card's math against a vial priced by the milligram rather than the fill, research-grade tirzepatide follows an entirely separate pricing structure, covered later in this guide.

The Mounjaro savings card, and why it is not the same coupon

Mounjaro and Zepbound share the same active molecule, but Lilly runs the coupon programs separately because the FDA-approved indications are different: Mounjaro for type 2 diabetes, Zepbound for chronic weight management. ^[3] ^[4] The Mounjaro savings card mirrors the Zepbound structure in mechanism, up to 150 dollars off a fill for a commercially insured patient, but the annual cap is higher, up to 1,950 dollars a year, and eligibility is tied to the diabetes indication the prescription is written against. ^[2] A prescription for Mounjaro written off-label for weight loss sits outside the program's stated terms, since Mounjaro itself is not FDA-approved for that use. ^[2] ^[4]

The practical takeaway is that the brand on the prescription, not just the molecule, determines which card applies, and a patient cannot swap between the two programs to chase whichever cap happens to be larger that month.

Why pharmacy discount cards like GoodRx rarely move the price on a brand-name GLP-1

Pharmacy discount cards work by negotiating a discounted cash price at a participating pharmacy, then billing that price instead of the pharmacy's undiscounted list price. That mechanism is most powerful on generic drugs, where multiple manufacturers compete on the same molecule and a discount card can route a claim to whichever pharmacy has the lowest negotiated rate. Tirzepatide has no generic equivalent yet, so a discount card is negotiating a small markdown off a single manufacturer's list price rather than shopping across competing generics, and the resulting quote often lands close to, or even above, what LillyDirect's own self-pay program already charges without any card at all.

That does not make a discount card worthless, since comparing its quote against LillyDirect and against a single tirzepatide vial in the research market before committing to a route costs nothing and sometimes surfaces a genuinely lower number at a specific local pharmacy. It does mean a discount card should be treated as one quote to compare, not an automatic winner, the way it often is for a generic prescription.

Patient assistance programs for people without insurance

Separately from either savings card, income-based patient assistance programs exist to provide free or significantly reduced-cost medication to patients who meet income and insurance-status criteria, typically uninsured or underinsured individuals below a defined income threshold. These programs require an application, proof of income, and a valid prescription, and they process on a slower timeline than a savings card activated at the pharmacy counter. They are worth investigating specifically for anyone who does not qualify for either manufacturer savings card because they lack commercial insurance entirely, since that is precisely the gap patient assistance programs are designed to fill, distinct from the insured-patient copay gap the savings cards address.

Why none of these coupons apply to compounded or research-use tirzepatide

This is the structural point that trips up the most searches for a tirzepatide coupon: every mechanism above, the two manufacturer savings cards, pharmacy discount cards, and patient assistance programs, processes a claim against a specific manufacturer's National Drug Code at a licensed, prescription-dispensing pharmacy. Compounded tirzepatide, prepared by a 503A or 503B pharmacy under its own patient-specific order, is not sold under Lilly's NDC, so a Lilly-branded coupon has no claim to attach to. Research-use tirzepatide is a further step removed, since it is not dispensed through a pharmacy at all, carries no prescription, and is explicitly not intended for human use, which places it entirely outside the billing infrastructure every coupon in this guide depends on. Research-use tirzepatide sold here is priced per vial for exactly that reason, a market with no pharmacy claim to discount in the first place.

That is not a loophole to route around, it is simply a different, parallel market with its own pricing, covered in full in how to get tirzepatide cheaper. Anyone comparing a manufacturer coupon's discounted copay against a research-market vial price is comparing two numbers that were never on the same billing system to begin with.

What actually lowers the price if you're buying research-use tirzepatide

Since no coupon or savings card reaches the research-compound market, the levers that actually move the price there are different: order size, since a supplier's fixed costs like independent lab testing and cold-chain shipping spread across more milligrams in a larger order; comparing tirzepatide priced per vial across a small number of verified suppliers rather than defaulting to the first listing found; and avoiding the false economy of a price so far below the field that it usually means a skipped verification step rather than a genuine discount. The full ranked breakdown of every access route, insurance, LillyDirect, and the research market, normalized to a real cost per milligram, is in how to get tirzepatide cheaper, and the monthly budget math across a full titration schedule is in how much tirzepatide costs per month.

Common mistakes people make chasing a tirzepatide coupon

Assuming a manufacturer savings card lowers a cash-pay or research-market price, when it only ever discounts an insurance-billed pharmacy claim.
Applying for the Zepbound card with a Mounjaro prescription, or the reverse, when the two programs are brand-specific and matched to different indications.
Comparing a discount card's quoted price against list price instead of against LillyDirect's flat self-pay tiers, which are often the more competitive number for an uninsured, brand-name purchase.
Skipping the income and insurance-type eligibility rules on a savings card, then being surprised when a claim is rejected at the pharmacy counter after the fact.
Assuming a "compounded tirzepatide coupon" search result represents a manufacturer program, when compounded product is never billed under the manufacturer's own discount infrastructure.

Is a tirzepatide coupon worth pursuing before other routes

For anyone with commercial insurance that already covers Zepbound or Mounjaro, checking the matching savings card first makes sense, since it is free to enroll and the savings, up to 150 dollars a fill, are real when the eligibility terms are met. For anyone without that specific coverage, the more useful comparison is between LillyDirect's self-pay tiers, a pharmacy discount card's quoted price, a patient assistance program's income-based terms, and the research-compound market's per-milligram pricing, side by side, rather than searching for a single coupon that was never going to bridge all four. The complete clinical and mechanism background behind the compound itself is in the complete tirzepatide guide.

Frequently asked questions

Is there a coupon or savings card for tirzepatide?: Yes, but only for the two FDA-approved brands, sold under separate programs. Eli Lilly's Zepbound savings card can lower an eligible commercially insured patient's copay by up to 150 dollars per fill, with a 25 dollar minimum payment and an annual cap. The Mounjaro savings card works the same way for the type 2 diabetes indication. Neither is a universal coupon, and neither applies outside a pharmacy-filled, insurance-billed prescription.
Can I use GoodRx or SingleCare for tirzepatide?: A pharmacy discount card will generate a price at a participating pharmacy, but for a brand-name drug with no generic equivalent, that price is often close to or above the manufacturer's own cash-pay program, since discount cards work by negotiating off a pharmacy's list price rather than replacing it with a flat program price. It is worth comparing the discount card's quote against LillyDirect's self-pay tiers before assuming the discount card is cheaper.
Do savings cards or coupons work with compounded or research-use tirzepatide?: No. Manufacturer savings cards and pharmacy discount cards both process against a National Drug Code at a licensed pharmacy billing a specific prescription. Compounded tirzepatide is not sold under the manufacturer's NDC, and research-use material is not dispensed through a pharmacy at all, so there is no billing pathway for either program to apply to.
What if I don't have insurance and can't use a savings card?: A few routes remain. LillyDirect's self-pay program offers a flat cash price independent of insurance, patient assistance programs provide free or reduced-cost medication to qualifying uninsured patients on an income basis, and the research-compound market is a separate, uninsured-by-design lane entirely. The full route-by-route cost comparison is in how to get tirzepatide cheaper.
Does the Zepbound savings card work for a Mounjaro prescription, or the reverse?: No. Zepbound and Mounjaro are the same molecule under two brand names tied to two different FDA-approved indications, chronic weight management and type 2 diabetes respectively, and Lilly runs a separate savings card for each, matched to the prescription's specific indication and brand.

Glossary

Manufacturer savings card: A brand-specific coupon issued by the drug manufacturer that lowers an insured patient's copay at the pharmacy counter, activated against a specific insurance-billed claim.
National Drug Code (NDC): The identifier a pharmacy's billing system uses to match a dispensed product to a specific manufacturer, package, and strength, the mechanism every coupon and discount card claims against.
Pharmacy discount card: A third-party program, such as GoodRx or SingleCare, that negotiates a cash price at participating pharmacies independent of insurance.
Patient assistance program (PAP): An income-based manufacturer or nonprofit program that provides free or reduced-cost medication to qualifying uninsured or underinsured patients.
Cash price / self-pay: A price paid directly, without insurance billing, either through a manufacturer's own direct-to-consumer program or at a pharmacy without a coupon applied.
Research use only (RUO): Material supplied for laboratory or in-vitro study, explicitly not intended, tested, or approved for human use, and not dispensed through a pharmacy.

References

Eli Lilly and Company. Zepbound Savings & Insurance Options (accessed 2026).
Eli Lilly and Company. Mounjaro Savings & Coverage (accessed 2026).
U.S. Food and Drug Administration. Zepbound (tirzepatide) Prescribing Information, chronic weight management indication.
U.S. Food and Drug Administration. Mounjaro (tirzepatide) Prescribing Information, type 2 diabetes indication.

For research and educational purposes only. Not medical advice. Coupon, savings card, and pricing terms described here reflect publicly available manufacturer and pharmacy programs as of the publish date and can change or end at any time; confirm current terms directly with the program before relying on them. Nothing here instructs anyone to self-administer a research compound or to circumvent a prescription requirement. Tirzepatide is FDA approved under the brand names Mounjaro and Zepbound; the research-compound version discussed here for sourcing purposes is not approved for human use.